Selective biochemical and synthetic biology approaches for improved delivery of recombinant proteins to the extracellular milieu
用于改善重组蛋白向细胞外环境的递送的选择性生化和合成生物学方法
基本信息
- 批准号:BB/I020756/1
- 负责人:
- 金额:$ 56.59万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2011
- 资助国家:英国
- 起止时间:2011 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The biotechnology industry produces revenues in excess of £500 billion per year. This industry relies on the production of proteins to produce biopharmaceuticals (novel drugs and vaccines), bioproducts for use in food production and in foods (animal health-care biologics, biological plant-growth promoters and pesticides, nutritional supplements, and food additives), bioremediation to clean up the environment (e.g. enzymes to break down oil after oil spillages) and may offer alternatives to environmentally polluting or fossil-fuel-consuming manufacturing processes (e.g. methods to produce hydrogen from bacteria; industrial catalysts). The standard mechanism for making proteins is to produce them in a non-pathogenic bacterium called E. coli. However, there are limits to the types of protein that can be produced in E. coli. As most of these proteins are not derived from E. coli and are produced at levels much greater than E. coli would normally produce any natural protein, the E. coli bacterium often deals with them by storing the proteins in an inactive form in a compartment of the cell called the inclusion body. The accumulation of proteins in inclusion bodies causes problems for commercial production, including expensive steps to recover the proteins in an active conformation. To overcome these problems some proteins are produced in another compartment of the cell called the periplasm. However, if too much protein is made in the periplasm it can burst the cell open, killing the cell in the process, and therefore little or no protein is produced. Even those that are stable when produced in the periplasm will need expensive purification as there are many other native E. coli proteins in this part of the cell. When expressing a non-native protein the best place for the E. coli bacterium to place the protein is outside of the cell - this prevents accumulation of the protein in inclusion bodies or in the periplasm which might lead to cell death. In addition, the laboratory strains of E. coli produce none, or very little, native proteins outside of the cell. Thus, when proteins are produce outside the cell they are relatively clean and need much less effort and investment to bring them to purity. However, for a number of technical reasons it has proved to be very difficult to produce proteins outside the bacterial cell. Here we will utilise a very simple system called the Autotransporter system which has a proven track record for producing non-native proteins outside of the cell. We have already used this system to produce a proteins relevant to industry proving the system works. We will now attempt to make the system produce proteins at levels which are beneficial to industry.
生物技术产业每年产生超过5000亿英镑的收入。该行业依靠生产蛋白质来生产生物药品(新药和疫苗)、食品生产和食品中使用的生物产品(动物保健生物制剂、生物植物生长促进剂和农药、营养补充剂和食品添加剂)。清洁环境的生物修复(例如,在石油泄漏后分解石油的酶),并可能为污染环境或消耗化石燃料的制造过程(例如,从细菌中产生氢的方法;工业催化剂)提供替代方案。制造蛋白质的标准机制是在一种叫做大肠杆菌的非致病性细菌中产生蛋白质。然而,大肠杆菌中可以产生的蛋白质类型是有限的。由于这些蛋白质中的大多数不是来自大肠杆菌,其产生的水平远远高于大肠杆菌通常产生的任何天然蛋白质,因此大肠杆菌通常通过将蛋白质以非活性形式储存在称为包涵体的细胞隔间中来处理它们。包涵体中蛋白质的积累给商业生产带来了问题,包括恢复活性构象的昂贵步骤。为了克服这些问题,一些蛋白质在细胞的另一个称为周质的隔室中产生。然而,如果在周质中产生过多的蛋白质,它会使细胞破裂,在这个过程中杀死细胞,因此很少或根本不产生蛋白质。即使是那些在周质中产生的稳定蛋白也需要昂贵的纯化,因为在细胞的这一部分还有许多其他天然的大肠杆菌蛋白。当表达非天然蛋白质时,大肠杆菌放置蛋白质的最佳位置是在细胞外,这可以防止蛋白质在包涵体或周质中积聚,从而可能导致细胞死亡。此外,大肠杆菌的实验室菌株在细胞外不产生或只产生很少的天然蛋白质。因此,当蛋白质在细胞外产生时,它们是相对清洁的,需要更少的努力和投资来达到纯度。然而,由于一些技术原因,在细菌细胞外生产蛋白质被证明是非常困难的。在这里,我们将利用一种非常简单的系统,称为Autotransporter系统,它在细胞外产生非天然蛋白质方面有良好的记录。我们已经用这个系统生产了一种与工业相关的蛋白质,证明了这个系统是有效的。我们现在将尝试使该系统生产对工业有益的蛋白质。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mutational and topological analysis of the Escherichia coli BamA protein.
- DOI:10.1371/journal.pone.0084512
- 发表时间:2013
- 期刊:
- 影响因子:3.7
- 作者:Browning DF;Matthews SA;Rossiter AE;Sevastsyanovich YR;Jeeves M;Mason JL;Wells TJ;Wardius CA;Knowles TJ;Cunningham AF;Bavro VN;Overduin M;Henderson IR
- 通讯作者:Henderson IR
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ian Henderson其他文献
Centrophilic retrotransposon integration via CENH3 chromatin in Arabidopsis
通过拟南芥中 CENH3 染色质的中心粒亲合逆转座子整合
- DOI:
10.1038/s41586-024-08319-7 - 发表时间:
2025-01-01 - 期刊:
- 影响因子:48.500
- 作者:
Sayuri Tsukahara;Alexandros Bousios;Estela Perez-Roman;Sota Yamaguchi;Basile Leduque;Aimi Nakano;Matthew Naish;Akihisa Osakabe;Atsushi Toyoda;Hidetaka Ito;Alejandro Edera;Sayaka Tominaga;Juliarni;Kae Kato;Shoko Oda;Soichi Inagaki;Zdravko Lorković;Kiyotaka Nagaki;Frédéric Berger;Akira Kawabe;Leandro Quadrana;Ian Henderson;Tetsuji Kakutani - 通讯作者:
Tetsuji Kakutani
Making a small enzyme smaller; removing the conserved loop structure of hen lysozyme
将小酶变小;
- DOI:
10.1016/0014-5793(94)00543-5 - 发表时间:
1994 - 期刊:
- 影响因子:3.5
- 作者:
R. Pickersgill;Katherine Varvill;S. Jones;B. Perry;B. Fischer;Ian Henderson;S. Garrard;I. Sumner;P. Goodenough - 通讯作者:
P. Goodenough
Severe maternal morbidity in the high income setting: a systematic review of composite definitions
高收入环境中的严重孕产妇发病率:对综合定义的系统综述
- DOI:
10.1016/j.eclinm.2025.103105 - 发表时间:
2025-03-01 - 期刊:
- 影响因子:10.000
- 作者:
Ian Henderson;Rosie Lynch;Stephen Gerry;Jenny McLeish;Peter Watkinson;Marian Knight - 通讯作者:
Marian Knight
Disseminating laparoscopic skills for endometrial cancer
- DOI:
10.1016/j.ejogrb.2018.08.299 - 发表时间:
2019-03-01 - 期刊:
- 影响因子:
- 作者:
Ian Henderson;Queenie Menezes - 通讯作者:
Queenie Menezes
SAFER: Electronic risk management for aspirin prophylaxis in pre-eclampsia
- DOI:
10.1016/j.ejogrb.2018.08.479 - 发表时间:
2019-03-01 - 期刊:
- 影响因子:
- 作者:
Ian Henderson;Brian Magowan - 通讯作者:
Brian Magowan
Ian Henderson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ian Henderson', 18)}}的其他基金
Validation of Early Warning Systems for Severe Maternal Morbidity and Individualised Prediction of Severe Maternal Morbidity within Ethnic Groups
严重孕产妇发病早期预警系统的验证以及族群内严重孕产妇发病的个性化预测
- 批准号:
MR/X006115/1 - 财政年份:2023
- 资助金额:
$ 56.59万 - 项目类别:
Fellowship
Assembling and recombining the Arabidopsis centromeres
组装和重组拟南芥着丝粒
- 批准号:
BB/V003984/1 - 财政年份:2021
- 资助金额:
$ 56.59万 - 项目类别:
Research Grant
AAFC IWYP Aligned Call; Circadian clock editing in wheat
AAFC IWYP 一致呼吁;
- 批准号:
BB/T004282/1 - 财政年份:2019
- 资助金额:
$ 56.59万 - 项目类别:
Research Grant
18-BTT: High-throughput fluorescent crossover reporters to dissect control of tomato meiotic recombination
18-BTT:高通量荧光交叉记者剖析番茄减数分裂重组的控制
- 批准号:
BB/S020012/1 - 财政年份:2019
- 资助金额:
$ 56.59万 - 项目类别:
Research Grant
HEI10: a master switch for recombination in plants
HEI10:植物重组的主开关
- 批准号:
BB/S006842/1 - 财政年份:2019
- 资助金额:
$ 56.59万 - 项目类别:
Research Grant
EpiSpiX - Unlocking plant genetic diversity via epi-modification & targeted recombination.
EpiSpiX - 通过表观修饰解锁植物遗传多样性
- 批准号:
BB/N007557/1 - 财政年份:2016
- 资助金额:
$ 56.59万 - 项目类别:
Research Grant
Pathfinder: Determining the efficacy of plasmapheresis as a treatment for patients with chronic Pseudomonas infections and inhibitory antibodies
探路者:确定血浆置换术治疗慢性假单胞菌感染和抑制性抗体患者的疗效
- 批准号:
MR/N027027/1 - 财政年份:2016
- 资助金额:
$ 56.59万 - 项目类别:
Research Grant
Understanding phopspholipid homeostasis in Gram-negative bacteria
了解革兰氏阴性菌中的磷脂稳态
- 批准号:
BB/M00810X/1 - 财政年份:2015
- 资助金额:
$ 56.59万 - 项目类别:
Research Grant
13 ERA-CAPS. Delineating the crossover control networks in plants (DeCOP)
13 ERA-CAPS。
- 批准号:
BB/M004937/1 - 财政年份:2014
- 资助金额:
$ 56.59万 - 项目类别:
Research Grant
MicrobesNG: A scalable replicable biological sample repository incorporating whole-genome sequence data and analysis of thousands of microbial strains
MicrobesNG:一个可扩展的可复制生物样本库,包含全基因组序列数据和数千种微生物菌株的分析
- 批准号:
BB/L024209/1 - 财政年份:2014
- 资助金额:
$ 56.59万 - 项目类别:
Research Grant
相似海外基金
Studies of Chemically Labile Alkylation Damage in DNA
DNA 中化学不稳定烷基化损伤的研究
- 批准号:
10735154 - 财政年份:2023
- 资助金额:
$ 56.59万 - 项目类别:
Diagnostic aptamer reagents to develop multi-analyte blood test for pre-clinical, mild and moderate Alzheimer's disease
诊断适体试剂用于开发针对临床前、轻度和中度阿尔茨海默病的多分析物血液检测
- 批准号:
10597840 - 财政年份:2023
- 资助金额:
$ 56.59万 - 项目类别:
Orthogonal split luciferases for imaging multiplexed cellular behaviors
用于多重细胞行为成像的正交分裂荧光素酶
- 批准号:
10730660 - 财政年份:2023
- 资助金额:
$ 56.59万 - 项目类别:
Toward synthetic chemically defined mRNA for human therapeutics
用于人类治疗的合成化学定义的 mRNA
- 批准号:
10649299 - 财政年份:2023
- 资助金额:
$ 56.59万 - 项目类别:
Cellular FM-radios: seeing, probing, and perturbing single-cell protein activity dynamics in biological systems with frequency-barcoded spatiotemporal signaling circuits
细胞调频无线电:利用频率条形码时空信号电路观察、探测和扰动生物系统中的单细胞蛋白质活性动态
- 批准号:
10685132 - 财政年份:2023
- 资助金额:
$ 56.59万 - 项目类别:
Chemical strategies to investigate biochemical crosstalk in human chromatin
研究人类染色质生化串扰的化学策略
- 批准号:
10621634 - 财政年份:2023
- 资助金额:
$ 56.59万 - 项目类别:
Utilizing the power of synthetic biology and De Novo design for the overexpression and biochemical stabilization of KCNA6 or Kv1.6 potassium channels in the E. coli expression system
利用合成生物学和 De Novo 设计的力量,实现大肠杆菌表达系统中 KCNA6 或 Kv1.6 钾通道的过度表达和生化稳定
- 批准号:
10666856 - 财政年份:2023
- 资助金额:
$ 56.59万 - 项目类别:
Structural systems biology of microenvironmental oxidative stress and synthetic biology intervention
微环境氧化应激的结构系统生物学与合成生物学干预
- 批准号:
10715112 - 财政年份:2023
- 资助金额:
$ 56.59万 - 项目类别:
Biosynthesis of marine terpenoid natural products
海洋萜类天然产物的生物合成
- 批准号:
10737210 - 财政年份:2023
- 资助金额:
$ 56.59万 - 项目类别:














{{item.name}}会员




